203 related articles for article (PubMed ID: 22117551)
41. Abrogation of glucocorticoid receptor dimerization correlates with dissociated glucocorticoid behavior of compound a.
Robertson S; Allie-Reid F; Vanden Berghe W; Visser K; Binder A; Africander D; Vismer M; De Bosscher K; Hapgood J; Haegeman G; Louw A
J Biol Chem; 2010 Mar; 285(11):8061-75. PubMed ID: 20037160
[TBL] [Abstract][Full Text] [Related]
42. Effects of the selective glucocorticoid receptor modulator compound A on bone metabolism and inflammation in male mice with collagen-induced arthritis.
Rauner M; Thiele S; Sinningen K; Winzer M; Salbach-Hirsch J; Gloe I; Peschke K; Haegeman G; Tuckermann JP; Hofbauer LC
Endocrinology; 2013 Oct; 154(10):3719-28. PubMed ID: 23885015
[TBL] [Abstract][Full Text] [Related]
43. PS-341 (Bortezomib) inhibits proliferation and induces apoptosis of megakaryoblastic MO7-e cells.
Galimberti S; Canestraro M; Pacini S; Fazzi R; Orciuolo E; Trombi L; Mattii L; Battolla B; Capodanno A; Collecchi P; Veroni F; Simi P; Piaggi S; Casini A; Petrini M
Leuk Res; 2008 Jan; 32(1):103-12. PubMed ID: 17629554
[TBL] [Abstract][Full Text] [Related]
44. The proteasome inhibitor bortezomib disrupts tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression and natural killer (NK) cell killing of TRAIL receptor-positive multiple myeloma cells.
Feng X; Yan J; Wang Y; Zierath JR; Nordenskjöld M; Henter JI; Fadeel B; Zheng C
Mol Immunol; 2010 Aug; 47(14):2388-96. PubMed ID: 20542572
[TBL] [Abstract][Full Text] [Related]
45. Bortezomib inhibits nuclear factor-kappaB dependent survival and has potent in vivo activity in mesothelioma.
Sartore-Bianchi A; Gasparri F; Galvani A; Nici L; Darnowski JW; Barbone D; Fennell DA; Gaudino G; Porta C; Mutti L
Clin Cancer Res; 2007 Oct; 13(19):5942-51. PubMed ID: 17908991
[TBL] [Abstract][Full Text] [Related]
46. Competition between glucocorticoid receptor and NFkappaB for control of the human FasL promoter.
Novac N; Baus D; Dostert A; Heinzel T
FASEB J; 2006 Jun; 20(8):1074-81. PubMed ID: 16770006
[TBL] [Abstract][Full Text] [Related]
47. Quantification and glucocorticoid regulation of glucocorticoid receptor transcripts in two human leukemic cell lines.
Pedersen KB; Vedeckis WV
Biochemistry; 2003 Sep; 42(37):10978-90. PubMed ID: 12974633
[TBL] [Abstract][Full Text] [Related]
48. Effects of the proteasome inhibitor, bortezomib, on apoptosis in isolated lymphocytes obtained from patients with chronic lymphocytic leukemia.
Pahler JC; Ruiz S; Niemer I; Calvert LR; Andreeff M; Keating M; Faderl S; McConkey DJ
Clin Cancer Res; 2003 Oct; 9(12):4570-7. PubMed ID: 14555532
[TBL] [Abstract][Full Text] [Related]
49. Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer.
Chen Z; Lan X; Wu D; Sunkel B; Ye Z; Huang J; Liu Z; Clinton SK; Jin VX; Wang Q
Nat Commun; 2015 Sep; 6():8323. PubMed ID: 26374485
[TBL] [Abstract][Full Text] [Related]
50. Interplay of the inflammatory and stress systems in a hepatic cell line: interactions between glucocorticoid receptor agonists and interleukin-6.
Visser K; Smith C; Louw A
Endocrinology; 2010 Nov; 151(11):5279-93. PubMed ID: 20881254
[TBL] [Abstract][Full Text] [Related]
51. Compound A, a dissociated glucocorticoid receptor modulator, inhibits T-bet (Th1) and induces GATA-3 (Th2) activity in immune cells.
Liberman AC; Antunica-Noguerol M; Ferraz-de-Paula V; Palermo-Neto J; Castro CN; Druker J; Holsboer F; Perone MJ; Gerlo S; De Bosscher K; Haegeman G; Arzt E
PLoS One; 2012; 7(4):e35155. PubMed ID: 22496903
[TBL] [Abstract][Full Text] [Related]
52. Compound A, a selective glucocorticoid receptor agonist, inhibits immunoinflammatory diabetes, induced by multiple low doses of streptozotocin in mice.
Saksida T; Vujicic M; Nikolic I; Stojanovic I; Haegeman G; Stosic-Grujicic S
Br J Pharmacol; 2014 Dec; 171(24):5898-909. PubMed ID: 25158597
[TBL] [Abstract][Full Text] [Related]
53. Differential cytokine profiles upon comparing selective versus classic glucocorticoid receptor modulation in human peripheral blood mononuclear cells and inferior turbinate tissue.
Beck IM; Van Crombruggen K; Holtappels G; Daubeuf F; Frossard N; Bachert C; De Bosscher K
PLoS One; 2015; 10(4):e0123068. PubMed ID: 25875480
[TBL] [Abstract][Full Text] [Related]
54. The rigid steroid 21-hydroxy-6,19-epoxyprogesterone (21OH-6,19OP) is a dissociated glucocorticoid receptor modulator potentially useful as a novel coadjuvant in breast cancer chemotherapy.
Orqueda AJ; Dansey MV; Español A; Veleiro AS; Bal de Kier Joffé E; Sales ME; Burton G; Pecci A
Biochem Pharmacol; 2014 Jun; 89(4):526-35. PubMed ID: 24735610
[TBL] [Abstract][Full Text] [Related]
55. Erg and AP-1 as determinants of glucocorticoid response in acute lymphoblastic leukemia.
Chen DW; Saha V; Liu JZ; Schwartz JM; Krstic-Demonacos M
Oncogene; 2013 Jun; 32(25):3039-48. PubMed ID: 22869147
[TBL] [Abstract][Full Text] [Related]
56. Effect of the plant derivative Compound A on the production of corticosteroid-resistant chemokines in airway smooth muscle cells.
Gavrila A; Chachi L; Tliba O; Brightling C; Amrani Y
Am J Respir Cell Mol Biol; 2015 Nov; 53(5):728-37. PubMed ID: 25897650
[TBL] [Abstract][Full Text] [Related]
57. Compound A inhibits urothelial tumorigenesis via both the androgen receptor and glucocorticoid receptor signaling pathways.
Ide H; Inoue S; Mizushima T; Jiang G; Nagata Y; Goto T; Kashiwagi E; Miyamoto H
Am J Transl Res; 2020; 12(5):1779-1788. PubMed ID: 32509176
[TBL] [Abstract][Full Text] [Related]
58. Mapping of glucocorticoid receptor DNA binding domain surfaces contributing to transrepression of NF-kappa B and induction of apoptosis.
Tao Y; Williams-Skipp C; Scheinman RI
J Biol Chem; 2001 Jan; 276(4):2329-32. PubMed ID: 11106637
[TBL] [Abstract][Full Text] [Related]
59. Compound A, a dissociated glucocorticoid receptor modulator, reduces dengue virus-induced cytokine secretion and dengue virus production.
Suttitheptumrong A; Khunchai S; Panaampon J; Yasamut U; Morchang A; Puttikhunt C; Noisakran S; Haegeman G; Yenchitsomanus PT; Limjindaporn T
Biochem Biophys Res Commun; 2013 Jun; 436(2):283-8. PubMed ID: 23743190
[TBL] [Abstract][Full Text] [Related]
60. Glucocorticoid-receptor-gene defects and resistance to glucocorticoid-induced apoptosis in human leukemic cell lines.
Hala M; Hartmann BL; Böck G; Geley S; Kofler R
Int J Cancer; 1996 Nov; 68(5):663-8. PubMed ID: 8938150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
